Efficacy and Safety of HN2301 in Refractory Myasthenia Gravis(MG)

NCT06965309 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
9
Enrollment
INDUSTRY
Sponsor class

Stopped Change of registrant

Conditions

Interventions

Sponsor

Shenzhen MagicRNA Biotechnology Co., Ltd

Collaborators